Key Takeaways BWAY gained FDA clearance for an accelerated Deep TMS protocol for major depressive disorder.BWAY's new method shortens treatment to six days with results comparable to the standard approach.BWAY is preparing provider training and reimbursement updates to support wider adoption.BrainsWay Ltd. (BWAY) recently secured FDA clearance for an accelerated treatment protocol using its Deep Transcranial Magnetic Stimulation (TMS) system. The approval allows providers to treat patients with major depres ...